Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
To determine whether a combination of intravitreal aflibercept and pranoprofen eyedrops or
nutraceutical support provides additional benefit over IVA monotherapy for the treatment of
choroidal neovascularization in age-related macular degeneration.